Read More Pharma Industry News Aravive Biologics’ AVB-S6-500 receives FDA fast track designation for ovarian cancer Aravive Biologics, a biopharmaceutical company, has received Fast Track designation from the U.S. Food and Drug Administration (FDA)… bypharmanewsdailyAugust 20, 2018
